Condition: Metastatic Non-small Cell Lung Cancer (NSCLC) · Non-small Cell Lung Cancer Metastatic · Non-small Cell Lung Cancer Stage II · Sponsor: AIO-Studien-gGmbH
Open, non-interventional, prospective, multi-center clinical research platform with the main objective to assess molecular biomarker testing, treatment and outcome of patients with NSCLC or SCLC in Germany
This description comes directly from the study's public registry record.
Annika Groth · +49 30-8145344-39 · annika.groth@aio-studien-ggmb.de
Paula Ludwig · +49 30-8145344-63 · Paula.Ludwig@aio-studien-ggmbh.de
Always discuss trial participation with your own doctor first.
| Pius-Hospital | Oldenburg, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02622581